CVS Q3'26 Earnings: EPS estimate is 1.65 USD

What happened

CVS Health is scheduled to report its Q3'26 results on November 04 before the market opens, with the announcement expected at 6:30 AM ET. The listed estimates are revenue of 104.72 billion USD and earnings per share, or profit allocated to each share, of 1.65 USD.

Confirmed

Global impact / market context

The report will show whether CVS's sales and profit per share meet the stated estimates. A shortfall could raise concerns about the company's ability to generate revenue and earnings, while stronger results could support investor confidence; the article provides no actual Q3'26 results yet.

Analyst inference

The article lists earlier revenue and earnings-per-share results above their estimates, including revenue surprises and earnings surprises. Such comparisons can shape investor expectations for CVS, but they do not establish whether upcoming results will meet estimates or explain what drove earlier differences.

Analyst inference

What to watch

1. Check the reported Q3'26 revenue against the 104.72 billion USD estimate; sales below that level would indicate weaker revenue than the published expectation. Analyst inference
2. Compare reported earnings per share with the 1.65 USD estimate; this measure divides profit among shares and indicates whether profit per share met expectations. Analyst inference
3. The announcement is scheduled for November 04 at 6:30 AM ET, before the market opens; the article does not provide actual results or a confirmed release outcome. Confirmed

Evidence

• Original source link unavailable